A Selective role for dopamine D4 receptors in modulating reward expectancy in a rodent slot machine task

Biological Psychiatry

Volumn 75, Issue 10, 2014, Pages 817-824

  Cocker, Paul J ^a   Le Foll, Bernard ^b,c,d   Rogers, Robert D ^e   Winstanley, Catharine A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Anterior cingulate; gambling; incentive salience; L 745,870; near miss; quinpirole

Indexed keywords

DOPAMINE 4 RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; QUINPIROLE; RECEPTOR SUBTYPE; SODIUM CHLORIDE; 3-((4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)METHYL)-1H-PYRROLO(2,3-B)PYRIDINE; BENZAMIDE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; N-((4-(2-CYANOPHENYL)-1-PIPERAZINYL)METHYL)-3-METHYLBENZAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DECISION MAKING; ILLUMINATION; LATENT PERIOD; LIGHT; MALE; NONHUMAN; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PUNISHMENT; RAT; REWARD; REWARD EXPECTANCY; TASK PERFORMANCE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; HIGH RISK BEHAVIOR; LONG EVANS RAT; PHYSIOLOGY;

ANIMALS; BENZAMIDES; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; PIPERAZINES; PYRIDINES; PYRROLES; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D4; REWARD; RISK-TAKING;

EID: 84899632294     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.08.026     Document Type: Article

References (70)

1. J. MacKillop, E.J. Anderson, B.A. Castelda, R.E. Mattson, and P.J. Donovick Divergent validity of measures of cognitive distortions, impulsivity, and time perspective in pathological gambling J Gambl Stud 22 2006 339 354
2. N. Raylu, and T.P. Oei The Gambling Related Cognitions Scale (GRCS): Development, confirmatory factor validation and psychometric properties Addiction 99 2004 757 769
3. R.L. Reid The psychology of the near miss J Gambl Behav 2 1986 32 39
4. L. Clark Decision-making during gambling: An integration of cognitive and psychobiological approaches Philos Trans R Soc Lond B Biol Sci 365 2010 319 330
5. C.A. Winstanley, P.J. Cocker, and R.D. Rogers Dopamine modulates reward expectancy during performance of a slot machine task in rats: Evidence for a 'near-miss' effect Neuropsychopharmacology 36 2011 913 925
6. E.P. Noble Addiction and its reward process through polymorphisms of the D-2 dopamine receptor gene: A review Eur Psychiatry 15 2000 79 89
7. D.E. Comings, R.J. Rosenthal, H.R. Lesieur, L.J. Rugle, D. Muhleman, and C. Chiu et al. A study of the dopamine D2 receptor gene in pathological gambling Pharmacogenetics 6 1996 223 234
8. K. Blum, P.J. Sheridan, R.C. Wood, E.R. Braverman, T.J. Chen, J.G. Cull, and D.E. Comings The D2 dopamine receptor gene as a determinant of reward deficiency syndrome J R Soc Med 89 1996 396 400
9. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: An incentive-sensitization theory of addiction Brain Res Brain Res Rev 18 1993 247 291
10. S.B. Flagel, T.E. Robinson, J.J. Clark, S.M. Clinton, S.J. Watson, and P. Seeman et al. An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: Implications for addiction Neuropsychopharmacology 35 2010 388 400
11. A. Heinz, T. Siessmeier, J. Wrase, D. Hermann, S. Klein, and S.M. Grüsser et al. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving Am J Psychiatry 161 2004 1783 1789
12. C.A. Marsden Dopamine: The rewarding years Br J Pharmacol 147 suppl 1 2006 S136 S144
13. M. Jaber, S.W. Robinson, C. Missale, and M.G. Caron Dopamine receptors and brain function Neuropharmacology 35 1996 1503 1519
14. S.B. Caine, and G.F. Koob Modulation of cocaine self-administration in the rat through D-3 dopamine receptors Science 260 1993 1814 1816
15. B.R. Chemel, B.L. Roth, B. Armbruster, V.J. Watts, and D.E. Nichols WAY-100635 is a potent dopamine D4 receptor agonist Psychopharmacology (Berl) 188 2006 244 251
16. C.A. Heidbreder, E.L. Gardner, Z.X. Xi, P.K. Thanos, M. Mugnaini, J.J. Hagan, and C.R. Ashby Jr The role of central dopamine D3 receptors in drug addiction: A review of pharmacological evidence Brain Res Brain Res Rev 49 2005 77 105
17. C.A. Heidbreder, and A.H. Newman Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders Ann N Y Acad Sci 1187 2010 4 34
18. B. Le Foll, S.R. Goldberg, and P. Sokoloff The dopamine D3 receptor and drug dependence: Effects on reward or beyond? Neuropharmacology 49 2005 525 541
19. Z.X. Xi, J. Gilbert, A.C. Campos, N. Kline, C.R. Ashby Jr, and J.J. Hagan et al. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats Psychopharmacology (Berl) 176 2004 57 65
20. A.E. Higley, S.W. Kiefer, X. Li, J. Gaal, Z.X. Xi, and E.L. Gardner Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats Eur J Pharmacol 659 2011 187 192
21. M.A. Khaled, K. Farid Araki, B. Li, K.M. Coen, P.W. Marinelli, and J. Varga et al. The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking Int J Neuropsychopharmacol 13 2010 181 190
22. R.J. Beninger, and T.J. Banasikowski Dopaminergic mechanism of reward-related incentive learning: Focus on the dopamine D(3) receptor Neurotox Res 14 2008 57 70
23. K. Van Craenenbroeck, P. Rondou, and G. Haegeman The dopamine D4 receptor: Biochemical and signalling properties Cell Mol Life Sci 67 2010 1971 1986
24. H.H. Van Tol, J.R. Bunzow, H.C. Guan, R.K. Sunahara, P. Seeman, H.B. Niznik, and O. Civelli Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine Nature 350 1991 610 614
25. D.E. Comings, R. Gade-Andavolu, N. Gonzalez, S. Wu, D. Muhleman, and C. Chen et al. The additive effect of neurotransmitter genes in pathological gambling Clin Genet 60 2001 107 116
26. D.E. Comings, N. Gonzalez, S. Wu, R. Gade, D. Muhleman, and G. Saucier et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse Am J Med Genet 88 1999 358 368
27. T. Demiralp, C.S. Herrmann, M.E. Erdal, T. Ergenoglu, Y.H. Keskin, M. Ergen, and H. Beydagi DRD4 and DAT1 polymorphisms modulate human gamma band responses Cereb Cortex 17 2007 1007 1019
28. F.I. Tarazi, and R.J. Baldessarini Brain dopamine D(4) receptors: Basic and clinical status Int J Neuropsychopharmacol 2 1999 41 58
29. M.S. Kramer, B. Last, A. Getson, and S.A. Reines The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group Arch Gen Psychiatry 54 1997 567 572
30. J.N. Oak, J. Oldenhof, and H.H. Van Tol The dopamine D(4) receptor: One decade of research Eur J Pharmacol 405 2000 303 327
31. B. Le Foll, A. Gallo, Y. Le Strat, L. Lu, and P. Gorwood Genetics of dopamine receptors and drug addiction: A comprehensive review Behav Pharmacol 20 2009 1 17
32. N.M. Lauzon, and S.R. Laviolette Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: Implications for neuropsychiatric disorders Behav Brain Res 208 2010 12 22
33. N.M. Lauzon, S.F. Bishop, and S.R. Laviolette Dopamine D1 versus D4 receptors differentially modulate the encoding of salient versus nonsalient emotional information in the medial prefrontal cortex J Neurosci 29 2009 4836 4845
34. Y. Yan, A. Pushparaj, Y. Le Strat, I. Gamaleddin, C. Barnes, and Z. Justinova et al. Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats Neuropsychopharmacology 37 2012 685 696
35. R.N. Cardinal, and M.R.F. Aitken ANOVA for the Behavioural Sciences Researcher 2006 L. Erlbaum Mahwah, NJ
36. F. Chaperon, M.D. Tricklebank, L. Unger, and H.C. Neijt Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors Neuropharmacology 44 2003 1047 1053
37. J.R. St Onge, and S.B. Floresco Dopaminergic modulation of risk-based decision making Neuropsychopharmacology 34 2009 681 697
38. M. Guitart-Masip, B. Johansson, A. Fernandez-Teruel, A. Tobena, and L. Gimenez-Llort Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: Relationship to NGFI-A gene expression in the Calleja islands Psychopharmacology (Berl) 196 2008 39 49
39. P. Seeman, and H.H. Van Tol Dopamine receptor pharmacology Curr Opin Neurol Neurosurg 6 1993 602 608
40. M.J. Frank, and R.C. O'Reilly A mechanistic account of striatal dopamine function in human cognition: Psychopharmacological studies with cabergoline and haloperidol Behav Neurosci 120 2006 497 517
41. L. Gazi, I. Bobirnac, M. Danzeisen, E. Schupbach, A.T. Bruinvels, and S. Geisse et al. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor Br J Pharmacol 124 1998 889 896
42. L. Gazi, I. Bobirnac, M. Danzeisen, E. Schupbach, D. Langenegger, and B. Sommer et al. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells Br J Pharmacol 128 1999 613 620
43. A.O. Stewart, M.D. Cowart, R.B. Moreland, S.P. Latshaw, M.A. Matulenko, and P.A. Bhatia et al. Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning J Med Chem 47 2004 2348 2355
44. S. Patel, S. Freedman, K.L. Chapman, F. Emms, A.E. Fletcher, and M. Knowles et al. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor J Pharmacol Exp Ther 283 1997 636 647
45. M.L. Dodd, K.J. Klos, J.H. Bower, Y.E. Geda, K.A. Josephs, and J.E. Ahlskog Pathological gambling caused by drugs used to treat Parkinson disease Arch Neurol 62 2005 1377 1381
46. J.M. Beaulieu, and R.R. Gainetdinov The physiology, signaling, and pharmacology of dopamine receptors Pharmacol Rev 63 2011 182 217
47. A. Rivera, A. Penafiel, M. Megias, L.F. Agnati, J.F. Lopez-Tellez, and B. Gago et al. Cellular localization and distribution of dopamine D(4) receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks Neuroscience 155 2008 997 1010
48. M.A. Ariano, J. Wang, K.L. Noblett, E.R. Larson, and D.R. Sibley Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera Brain Res 752 1997 26 34
49. Z.U. Khan, A. Gutierrez, R. Martin, A. Penafiel, A. Rivera, and A. De La Calle Differential regional and cellular distribution of dopamine D2-like receptors: An immunocytochemical study of subtype-specific antibodies in rat and human brain J Comp Neurol 402 1998 353 371
50. R.J. Primus, A. Thurkauf, J. Xu, E. Yevich, S. McInerney, and K. Shaw et al. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1 J Pharmacol Exp Ther 282 1997 1020 1027
51. A. Rivera, B. Cuellar, F.J. Giron, D.K. Grandy, A. de la Calle, and R. Moratalla Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum J Neurochem 80 2002 219 229
52. L. Clark, A.J. Lawrence, F. Astley-Jones, and N. Gray Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry Neuron 61 2009 481 490
53. B. Forget, A. Pushparaj, and B. Le Foll Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction Biol Psychiatry 68 2010 265 271
54. A. Pushparaj, C. Hamani, W. Yu, D.S. Shin, B. Kang, J.N. Nobrega, and B. Le Foll Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors Neuropsychopharmacology 38 2012 690 698
55. L. Mrzljak, C. Bergson, M. Pappy, R. Huff, R. Levenson, and P.S. Goldman-Rakic Localization of dopamine D4 receptors in GABAergic neurons of the primate brain Nature 381 1996 245 248
56. N.R. McFarland, and S.N. Haber Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas J Neurosci 22 2002 8117 8132
57. E.G. Jones The Thalamus 1985 Plenum Press New York
58. B. Berger, A.M. Thierry, and M.A. Moyne Dopaminergic innervation of the rat prefrontal cortex: A fluoresence histochemical study Brain Res 106 1976 133 145
59. L. Descarries, B. Lemay, G. Doucet, and B. Berger Regional and laminar density of the dopamine innervation in adult rat cerebral cortex Neuroscience 21 1987 807 824
60. H.W. Berendse, Y. Galis-de Graaf, and H.J. Groenewegen Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat J Comp Neurol 316 1992 314 347
61. S.J. Boyson, P. McGonigle, and P.B. Molinoff Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain J Neurosci 6 1986 3177 3188
62. S.L. Vincent, Y. Khan, and F.M. Benes Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex J Neurosci 13 1993 2551 2564
63. S.B. Floresco, and M.T. Tse Dopaminergic regulation of inhibitory and excitatory transmission in the basolateral amygdala-prefrontal cortical pathway J Neurosci 27 2007 2045 2057
64. E.Y. Yuen, and Z. Yan Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex J Neurosci 29 2009 550 562
65. A. Ceci, A. Brambilla, P. Duranti, M. Grauert, N. Grippa, and F. Borsini Effect of antipsychotic drugs and selective dopaminergic antagonists on dopamine-induced facilitatory activity in prelimbic cortical pyramidal neurons. An in vitro study Neuroscience 93 1999 107 115
66. S.C. Dulawa, D.K. Grandy, M.J. Low, M.P. Paulus, and M.A. Geyer Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli J Neurosci 19 1999 9550 9556
67. J. Milstein, J. Dalley, and T. Robbins Methylphenidate-induced impulsivity: Pharmacological antagonism by {beta}-adrenoreceptor blockade J Psychopharmacol 24 2010 309 321
68. M.N. Koffarnus, A.H. Newman, P. Grundt, K.C. Rice, and J.H. Woods Effects of selective dopaminergic compounds on a delay-discounting task Behav Pharmacol 22 2011 300 311
69. J.R. St. Onge, and S.B. Floresco Dopaminergic regulation of risk-based decision-making Neuropsychopharmacology 34 2009 681 697
70. S. Floresco, O. Magyar, S. Ghods-Sharifi, C. Vexelman, and M. Tse Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting Neuropsychopharmacology 31 2006 297 309